Stephen Willey
Stock Analyst at Stifel
(4.17)
# 1,123
Out of 4,608 analysts
114
Total ratings
46.67%
Success rate
16.97%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stephen Willey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CUE Cue Biopharma | Maintains: Buy | $8 → $4 | $0.73 | +445.40% | 7 | Aug 20, 2024 | |
| INSM Insmed | Maintains: Buy | $74 → $88 | $73.02 | +20.51% | 4 | Aug 9, 2024 | |
| ZYME Zymeworks | Maintains: Buy | $20 → $21 | $12.39 | +69.49% | 5 | Aug 2, 2024 | |
| HLVX HilleVax | Downgrades: Hold | $34 → $3 | $1.80 | +66.67% | 3 | Jul 9, 2024 | |
| GERN Geron | Maintains: Buy | $6 → $7 | $4.44 | +57.66% | 2 | Jun 10, 2024 | |
| NRIX Nurix Therapeutics | Maintains: Buy | $27 | $21.97 | +22.89% | 3 | May 15, 2024 | |
| BOLT Bolt Biotherapeutics | Downgrades: Hold | $6 → $1.5 | $0.65 | +132.13% | 2 | May 15, 2024 | |
| MGNX MacroGenics | Downgrades: Hold | $29 → $7 | $3.53 | +98.30% | 2 | May 10, 2024 | |
| MEIP MEI Pharma | Maintains: Hold | $7 | $2.75 | +154.55% | 10 | Apr 12, 2024 | |
| VOR Vor Biopharma | Maintains: Buy | $15 → $12 | $0.66 | +1,719.56% | 4 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $68 | $67.63 | +0.55% | 4 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $17 | $2.48 | +585.48% | 3 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $23 → $25 | $26.50 | -5.66% | 15 | Feb 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $1.93 | +107.25% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $53 → $62 | $40.84 | +51.81% | 5 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $26 → $25 | $14.40 | +73.61% | 5 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $5 | $0.61 | +720.48% | 1 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $18 | $4.17 | +331.65% | 2 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $1.92 | +368.75% | 1 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $4.07 | +194.84% | 1 | Nov 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $228 → $288 | $5.66 | +4,988.34% | 4 | Jun 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $285 | $1.31 | +21,655.73% | 1 | Mar 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $21 | $1.31 | +1,503.05% | 2 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $10 → $4 | $1.61 | +148.45% | 7 | Jul 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $123 | $271.55 | -54.70% | 3 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $48 → $47 | $39.38 | +19.35% | 2 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $102 → $109 | $69.66 | +56.47% | 3 | Aug 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Terminates: Hold | n/a | $19.56 | - | 2 | Jun 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $25 | $0.15 | +16,133.77% | 5 | Mar 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $23 | $6.41 | +258.81% | 5 | Feb 7, 2018 |
Cue Biopharma
Aug 20, 2024
Maintains: Buy
Price Target: $8 → $4
Current: $0.73
Upside: +445.40%
Insmed
Aug 9, 2024
Maintains: Buy
Price Target: $74 → $88
Current: $73.02
Upside: +20.51%
Zymeworks
Aug 2, 2024
Maintains: Buy
Price Target: $20 → $21
Current: $12.39
Upside: +69.49%
HilleVax
Jul 9, 2024
Downgrades: Hold
Price Target: $34 → $3
Current: $1.80
Upside: +66.67%
Geron
Jun 10, 2024
Maintains: Buy
Price Target: $6 → $7
Current: $4.44
Upside: +57.66%
Nurix Therapeutics
May 15, 2024
Maintains: Buy
Price Target: $27
Current: $21.97
Upside: +22.89%
Bolt Biotherapeutics
May 15, 2024
Downgrades: Hold
Price Target: $6 → $1.5
Current: $0.65
Upside: +132.13%
MacroGenics
May 10, 2024
Downgrades: Hold
Price Target: $29 → $7
Current: $3.53
Upside: +98.30%
MEI Pharma
Apr 12, 2024
Maintains: Hold
Price Target: $7
Current: $2.75
Upside: +154.55%
Vor Biopharma
Mar 21, 2024
Maintains: Buy
Price Target: $15 → $12
Current: $0.66
Upside: +1,719.56%
Mar 12, 2024
Reiterates: Hold
Price Target: $68
Current: $67.63
Upside: +0.55%
Feb 21, 2024
Maintains: Buy
Price Target: $21 → $17
Current: $2.48
Upside: +585.48%
Feb 2, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $26.50
Upside: -5.66%
Dec 19, 2023
Maintains: Buy
Price Target: $3 → $4
Current: $1.93
Upside: +107.25%
Dec 18, 2023
Maintains: Buy
Price Target: $53 → $62
Current: $40.84
Upside: +51.81%
Nov 14, 2023
Maintains: Buy
Price Target: $26 → $25
Current: $14.40
Upside: +73.61%
May 17, 2023
Maintains: Buy
Price Target: $4 → $5
Current: $0.61
Upside: +720.48%
May 12, 2023
Maintains: Buy
Price Target: $21 → $18
Current: $4.17
Upside: +331.65%
Jan 27, 2023
Initiates: Buy
Price Target: $9
Current: $1.92
Upside: +368.75%
Nov 28, 2022
Initiates: Buy
Price Target: $12
Current: $4.07
Upside: +194.84%
Jun 26, 2020
Downgrades: Hold
Price Target: $228 → $288
Current: $5.66
Upside: +4,988.34%
Mar 25, 2020
Initiates: Buy
Price Target: $285
Current: $1.31
Upside: +21,655.73%
Mar 17, 2020
Maintains: Buy
Price Target: $22 → $21
Current: $1.31
Upside: +1,503.05%
Jul 29, 2019
Downgrades: Hold
Price Target: $10 → $4
Current: $1.61
Upside: +148.45%
Aug 13, 2018
Maintains: Buy
Price Target: $125 → $123
Current: $271.55
Upside: -54.70%
Aug 8, 2018
Maintains: Hold
Price Target: $48 → $47
Current: $39.38
Upside: +19.35%
Aug 3, 2018
Maintains: Buy
Price Target: $102 → $109
Current: $69.66
Upside: +56.47%
Jun 25, 2018
Terminates: Hold
Price Target: n/a
Current: $19.56
Upside: -
Mar 7, 2018
Maintains: Buy
Price Target: $23 → $25
Current: $0.15
Upside: +16,133.77%
Feb 7, 2018
Maintains: Buy
Price Target: $20 → $23
Current: $6.41
Upside: +258.81%